Table 3 Prognostic factors for overall survival in patients who received chemotherapy with gemcitabine and albumin-bound paclitaxel.
n | Hazard ratio (95% CI) | P value* | |
|---|---|---|---|
Age | |||
74≤ years old | 55 | reference | |
66–73 years old | 89 | 1.159 (0.807–1.664) | 0.42 |
≤65 years old | 80 | 1.357 (0.891–2.066) | 0.15 |
Sex | |||
Female | 95 | reference | |
Male | 129 | 1.395 (0.929–2.095) | 0.11 |
UICC stage | |||
I-II | 15 | reference | |
III | 40 | 1.074 (0.464–2.488) | 0.87 |
IV, Recurrent | 169 | 3.061 (1.469–6.377) | 0.003 |
CEA | |||
<5.3 ng/mL | 112 | reference | |
≥5.3 ng/mL | 112 | 1.125 (0.785–1.613) | 0.52 |
CA19-9 | |||
<1155 U/mL | 112 | reference | |
≥1155 U/mL | 112 | 1.356 (0.956–1.922) | 0.087 |
LG2m | |||
<34.9 pg/mL | 112 | reference | |
≥34.9 pg/mL | 112 | 1.781 (1.274–2.490) | <0.001 |